DCF — SAINT ALPHONSUS MEDICAL CENTER BAKER
Enterprise Value: $-48.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-48.2M
Enterprise Value
$-15.4M
PV of Cash Flows
$-32.8M
PV of Terminal Value
$-52.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $35.1M | $-2.9M | -8.0% | $-4.4M | $-4.0M |
| Year 2 | $36.1M | $-2.6M | -7.0% | $-4.2M | $-3.4M |
| Year 3 | $37.2M | $-2.3M | -6.0% | $-3.9M | $-2.9M |
| Year 4 | $38.3M | $-2.2M | -6.0% | $-3.8M | $-2.6M |
| Year 5 | $39.5M | $-2.2M | -6.0% | $-3.9M | $-2.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-48.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$34.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.08806076520659996
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5